Assessing horizontal equity in medication treatment among elderly Mexicans: Which socioeconomic determinants matter most?

Health Economics

Volumn 17, Issue 10, 2008, Pages 1153-1169

  Maurer, Jürgen ^a  

^a UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

Equity; Medication treatment; Mexico; Socioeconomic status

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEGENERATIVE DISEASE; ELDERLY CARE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; MEXICO; PRIORITY JOURNAL; SOCIAL STATUS; SOCIOECONOMICS;

ADULT; AGED; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE REFORM; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH; MALE; MEXICO; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PRESCRIPTION DRUGS; SOCIAL CLASS;

EID: 57349100871     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1313     Document Type: Article

References (30)

1. Andersen R. 1968. Behavioral model of families' use of health services. Research Series No. 25, Center for Health Administration Studies, University of Chicago, Chicago.
2. Andersen R. 1995. Revisiting the behavioral model of access to medical care: does it matter? Journal of Health and Social Behavior 36: 1-10.
3. Barraza-Lloréns M, Bertozzi S, Gonzáez-Pier E, Gutiérrez J. 2002. Addressing inequity in health and health care in Mexico. Health Affairs 21: 47-56.
4. Behrman J, Behrman J, Perez N. 2006. Where should UNU-WIDER place their bets? Some considerations for prioritizing future economic research on health and development. UNU-WIDER Conference on 'Advancing Health Equity', Helsinki, 2006.
5. Case A, le Roux I, Menendez A. 2004. Medical compliance and income-health gradients. American Economic Review Papers and Proceedings 94: 331-335.
6. Cetrángolo O, Cruces G, Titelman D. 2006. Social Protection and Health Systems in Latin America and the Caribbean. Economic Commission for Latin America and the Caribbean, Santiago de Chile.
7. Danzon P, Furukawa M. 2003. Prices and availability of pharmaceuticals: evidence from nine countries. Health Affairs (Web Exclusive) W3: 521-526.
8. Gakidou E, Lozano R, González-Pier E, Abbott-Klafter J, Barofsky JT, Bryson-Cahn C, Feehan DM, Lee DK, Hernández-Llamas H, Murray CJ. 2006. Assessing the effect of the 2001-06 Mexican health reform: an interim report card. The Lancet 368: 1920-1935.
9. Goldman D, Smith J. 2002. Can patient self-management help explain the SES health gradient. Proceedings of the National Academy of Sciences of the United States of America 99: 10929-10934.
10. Goldman D, Smith J. 2005. Socioeconomic differences in the adoption of new medical technologies. NBER Working Paper W11218, Cambridge, MA.
11. González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M, Porras-Condey R, Carvalho N, Loncich K, Dias R, Kulkarni S, Casey A, Murakami Y, Ezzati M, Salomon J. 2006. Priority setting for health interventions in Mexico's System of Social Protection in Health. The Lancet 368: 1608-1618.
12. Jacobzone S. 2003. Introduction to the ageing-related diseases project. OECD: A Disease-based Comparison of Health Systems: What is Best and at What Cost? OECD: Paris, 11-27.
13. Jamison D, Breman J, Measham A, Alleyne G, Claeson M, Evans D, Jha P, Mills A, Musgrove P (eds). 2006a. Priorities in Health. Oxford University Press, The World Bank: New York.
14. Jamison D, Breman J, Measham A, Alleyne G, Claeson M, Evans D, Jha P, Mills A, Musgrove P (eds). 2006b. Disease Control Priorities in Developing Countries (2nd edn). Oxford University Press, The World Bank: New York.
15. Knaul F, Frenk J. 2005. Health insurance in Mexico: achieving universal coverage through structural reform. Health Affairs 24: 1467-1476.
16. Lleras-Muney A, Lichtenberg F. 2002. The effect of education on medical technology adoption: are the more educated more likely to use new drugs. NBER Working Paper No. W9185, Cambridge, MA.
17. Lopez A, Mathers C, Ezzati M, Jamison D, Murray C. 2006. Global Burden of Disease and Risk Factors. Oxford University Press, The World Bank: New York.
18. Merino-Juárez M, Alarcón-Gómez M, Lozano-Ascencio R. 2004. SHA-based Health Accounts in 13 OECD Countries: Country Studies: Mexico: National Health Accounts 2001. OECD: Paris.
19. Ministry of Health. 2005. Hacia una política farmacéutica integral para México. Ministry of Health: Mexico City.
20. Moise P, Docteur E. 2007. Pharmaceutical pricing and reimbursement policies in Mexico. OECD Health Working Paper 25.
21. OECD. 2005a. OECD Review of Health Systems - Mexico. OECD: Paris.
22. OECD. 2005b. OECD Health Data 2005. OECD: Paris.
23. PAHO. 2002. Mortality Data 2002. PAHO: Washington, DC.
24. Pagán J, Puig A, Soldo B. 2007. Health insurance coverage and the use of preventive care services by Mexican adults. Health Economics. DOI: 10.1002/hec.1226.
25. Pagán J, Ross S, Yau J, Polsky D. 2006. Self-medication and health insurance coverage in Mexico. Health Policy 75: 170-177.
26. Palloni A, Soldo B, Wong R, Eniry M. 2004. Health Status in a National Sample of Elderly Mexicans. University of Wisconsin, Madison.
27. Perry G, Maloney W, Arias O, Fajnzylber P, Mason A, Saavedra-Chanduvi J. 2007. Informality: Exit and Exclusion. The World Bank: Washington.
28. Wagstaff A, van Doorslaer E. 2000. Equity in health care finance and delivery. In Handbook of Health Economics, Chapter 34, Cluyer A, Newhouse J (eds). Elsevier Science: Amsterdam, 1803-1862.
29. WHO. 2000. The benefits and risks of self-medication. WHO Drug Information 14: 1-2.
30. Wong R, Espinoza M. 2004. Imputation of Non-response on Economic Variables in the Mexican Health and Aging Study (MHAS/ENASEM) 2001, Population Studies Center, University of Pennsylvania, Philadelphia.